Non-Small Cell Lung Cancer Summit
EARN 5.25 SAMs/CME Credits and MOC points
As part of the clinical team pushing frontiers in diagnostic medicine, pathologists need to embrace a leadership role in improving patient care. ASCP is committed to providing opportunities for pathologists to come together with our partners on the clinical team to discuss and discover innovative solutions to case-based problems.
NSCLC Hands On Summit is an exciting new, complimentary CME summit that aims to study the unmet needs and clinical gaps in the care of patients with locally advanced and metastatic non-small cell lung cancer (NSCLC).
GAIN Live Summits feature an experiential learning theory-based instructional design with pre-course learning activities, flipped classroom, and interactive, participatory group and team-based workshop sessions. The multidisciplinary educational curriculum is designed for health-care providers to improve their knowledge, skills, and competence in the assessment and management of non-small cell lung cancer (NSCLC).
Content will address management of locally advanced and metastatic lung cancer by using multidisciplinary and multimodality approaches. These include conventional chemotherapy and biomarker-driven therapy, including immune checkpoint inhibitors that target to unleash or enhance preexisting anticancer immune responses. Examples of these immunotherapies target PD-1 antibodies, PD-L1 antibodies, and CTLA-4 antibodies. Genotype-driven therapy will be addressed by discussing agents that target genetic abnormalities, including but not limited to: EGFR, KRAS, BRAF mutations, and ALK and ROS1 translocations.
7 Summits are available for 5.25 SAMs/CME credits and MOC points
Reserve your spot in the summit with a $50 deposit refunded by a $50 VISA gift card at check-in at the event.
May 13, 2017